In case you missed it: CHI + Certara Webinar on Artificial Intelligence (AI) -Powered Model-Informed Drug Development (MIDD)
April 18, 2025 What’s next for drug development? Recapping our MIDD in the age of…
CertaraApril 18, 2025
Patient Services Strategy Fact Sheet
Certara’s Patient Services Strategy offering is flexible based on your budget and project type, and…
CertaraApril 18, 2025
Enabling Personalized Therapy with PBPK Modeling for Pediatric Epilepsy
GRIN Therapeutics, Inc., an affiliate of Neurvati Neurosciences, focuses on the research and development of…
CertaraApril 16, 2025
Best Practices for Visualization of Nonclinical Study Data in SEND Format (and Beyond)
Thank you for registering for our webinar, Best Practices for Visualization of Nonclinical Study Data…
CertaraApril 15, 2025
Using SDTM Data to Produce Patient Narratives
In this blog, we look at how medical writers can use SDTM data produced by…
CertaraApril 15, 2025
How to Use Fix Tips for Better Clinical Data Issue Management
April 15, 2025 Prior to submission to any regulatory agency, standardized study data is evaluated using at…
CertaraApril 15, 2025
Using cost-effectiveness models for smarter drug development and healthcare decisions
April 14, 2025 Editor’s note: This is the second in a series of four articles…
CertaraApril 14, 2025
Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing
New offering provides strategic guidance and AI-enabled biosimulation to navigate FDA’s Roadmap to Reducing Animal…
CertaraApril 14, 2025
